Sachs Associates would like to say that we have enjoyed hosting you back in-person and virtually and thank those who participated in our Sachs Spring Life Sciences Week, which incorporated the 5th Annual European HealthTech CEO Forum (Sachs_EHTF) and the 17th Annual European Life Sciences CEO Forum (Sachs_ELSF). A special thank you goes to the excellent line-up of sponsors, chairs, panellists, exhibitors and presenters who made such a broad and interesting programme possible and to those who participated in-person and during the virtual week.
The Life Sciences Week has proven to be successful in supporting our community with over 500 people from 30 countries registered and over 2000 in-person & online meetings completed.
Publicly available recordings of the sessions and presentations which took place during the event will be added in a couple of weeks on SachsTV YouTube channel.
We are looking forward to welcoming you again in our future events!
SILVER SPONSOR:
BRONZE SPONSORS:
CONTRIBUTING SPONSOR:
Presenting Companies Included:
AKIGAI AS
Exhibitors Included:
Confirmed Keynote Speakers Included:
Chris Roberts
Head of EMEA Issuer Services, Hong Kong Exchanges and Clearing Limited
Liesbeth Ceelen
CEO, BioLizard SA
Matthias Tschöp
Chief Executive Officer & Chief Scientific Officer, Helmholtz Munich
Speakers and Chairs Included:
Andreas Wallnoefer
Managing Director, ClavystBio
Antoine Boulanger
Partner, Apollo Health Ventures
Christian Thomsen
Global Head, CNS BD&L, Boehringer Ingelheim International GmbH
Esteban Pombo-Villar
Board Member, TargImmune Therapeutics AG
Evonne Sepsis
Managing Director, ESC Advisors
François Thomas
Operating Partner, Quadrille Capital
Georgia Frost
Vice President, Dementia Discovery Fund 2 L.P. (SV Health Investors)
Helen Chen
Global Sector Co-Head, Healthcare & Life Sciences | Greater China Managing Partner, L.E.K. Consulting
Katya Smirnyagina
Senior Partner, Oxford Science Enterprises
Michael Hübner
Director External Scientific Innovation, Johnson & Johnson Innovation LLC
Olav Zilian
Medical Advisor, FluoSphera SA
Richard Ward
Executive Director, Oncology Search & Evaluation, GSK
Sarah Holland
President of Swiss Healthcare Licensing Group & CBO, CDR-Life AG
Stephanie Léouzon
Managing Director & Vice Chair of European Healthcare Investment Banking, Stifel
Søren Møller
Managing Partner, Novo Holdings A/S
Victoria English
Co-Founder & Editor, Evernow Publishing Ltd, publisher of MedNous
Alessandra Polara
Senior Director, Global BD, F. Hoffmann-La Roche AG
Andreas Pahl
CEO, Heidelberg Pharma AG
Andreas Jurgeit
Partner, Gimv
Anna Lisa Picciolo-Lehrke
Head Business Development Neurology, UCB Pharma
Aram Mangasarian
CEO, TME Pharma
Bauke Anninga
Investment Director, M Ventures
Benjamin Thomas
Senior Vice President - Operations, Oxford BioTherapeutics Ltd.
Birgit Steckel-Hamann
Associate VP, External Innovation, Search & Evaluation, Cardiometabolic Health, Eli Lilly and Company
Chris Roberts
Head of EMEA Issuer Services, Hong Kong Exchanges and Clearing Limited
Christos Papadimitriou
Co-Founder & CEO, Tessara Therapeutics Pty Ltd.
Dani Bach
Managing Partner, Limani Partners
Daniel Parera
Partner, Kurma Partners
David Colpman
Director, Alpina Life Science Advisors
Donald Xu
Managing Partner, Lynx Financial Hong Kong Ltd.
Dragan Grabulovski
Founder & CEO, Grabulovski Consulting Services GmbH
Edouard Caram
Sr. Director, Global Partnership Rare Diseases & Neurosciences, Ipsen
Emin Fadillioglu
CEO, Eczacibasi Pharmaceutical and Industrial Investment Co.
Eric Halioua
Executive Chairman, Ervimmune
Francois Ravenelle
Founder & CEO, Inversago Pharma Inc.
Göran Forsberg
CEO, Cantargia AB
Jesus Baena
BD&L Transactions Oncology Director, Novartis AG
Jonathan Tobin
Partner, Brandon Capital
Josua Jordi
Chief Scientific Officer, Tanai Therapeutics
Khatereh Ahmadi
Venture Partner, XGEN Venture SGR S.p.A.
Klaus Breiner
Managing Partner, Pureos Bioventures
Klaus Dugi
CEO, Vandria SA
Konstantin Petropoulos
CEO, Secarna Pharmaceuticals GmbH & Co. KG
Lubor Gaal
CBO, MitoRx Therapeutics Limited
Lynn Durham
Founder & CEO, STALICLA SA
Marc Ditmarsch
Chief Development Officer, NewAmsterdam Pharma
Marc Robillard
CEO, Tagworks Pharmaceuticals BV
Maria Dahl
Executive Director, BD&L, Novartis Pharma AG
Marie Leblanc
Executive Director, Global Head of Account Management, Cell & Gene Technologies, Lonza AG
Mark Rayner
Managing Partner, GOLDTRACK Ventures GmbH
Michael Altorfer
CEO, Swiss Biotech Association
Nigel Sheail
Partner, Versant Ventures
Paul Hermant
Partner, Bird & Bird (Belgium) LLP
Peter Braun
CEO, TargImmune Therapeutics AG
Philip Larsen
CEO, SixPeaks Bio AG
Rianne Ellenbroek
Principal, BioGeneration Ventures
Sarah Holland
President of Swiss Healthcare Licensing Group & CBO, CDR-Life AG
Simon Chandler
CEO, Rinri Therapeutics Ltd.
Stacy Lindborg
Co-CEO, Brainstorm Cell Therapeutics, Inc.
Stefano Portolano
CEO, Azafaros Switzerland AG
Stephan Lensky
COO & CBO, EpimAb Biotherapeutics
Stephen Doyle
Chief Business Officer, Aslan Pharmaceuticals
Susan Hill
CEO, Mestag Therapeutics Ltd.
Tamas Schweighoffer
Co-Founding Partner, Forty51 Ventures AG
Tom Shepherd
CEO, Captor Therapeutics S.A.
Ulrich Wendt
Global Head Business Development Immunology & Inflammation, Sanofi